Puma Biotechnology | Bénéfice Avant Impôts

Prix De L'Action
6.62
Variation Quotidienne
0.01 0.12%
Mensuellement
5.38%
Annuel
137.20%
Q1 Prévisions
5.65




Bénéfice Avant Impôts Changement Date
Agios Pharmaceuticals USD -103.43M 8.59M 2025-09
Alnylam Pharmaceuticals USD 238.97M 274.33M 2025-09
Amgen USD 3.92B 2.35B 2025-09
Biogen USD 557.3M 186.7M 2025-09
BioMarin Pharmaceutical USD -26.32M 324.19M 2025-09
Daiichi Sankyo JPY 106.73B 48.96B 2025-12
Esperion Therapeutics USD 67.66M 3.6M 2024-09
Exelixis USD 252.69M 275K 2025-12
Gilead Sciences USD 3.64B 1.21B 2025-09
Glaxosmithkline GBP 2.46B 569M 2025-09
Incyte USD 482.31M 75.7M 2025-09
MacroGenics USD 16.82M 52.97M 2025-09
Moderna USD -187M 631M 2025-09
Novartis USD 4.2B 335M 2025-09
Pfizer USD 3.33B 290M 2025-09
PTC Therapeutics USD -23.07M 47.98M 2025-09
Puma Biotechnology USD 20.61M 24.76M 2024-09
Regeneron Pharmaceuticals USD 1.76B 244.6M 2025-09
Roche Holding CHF 4.79B 3.01B 2025-06
Sangamo BioSciences USD -36.05M 12.94M 2024-06
Sarepta Therapeutics USD -194.05M 347.69M 2025-09
Takeda JPY 133.86B 105.69B 2025-12
TG Therapeutics USD 25.91M 5.01M 2025-09
Ultragenyx Pharmaceutical USD -179.54M 65.54M 2025-09
Vanda Pharmaceuticals USD -22.92M 16.68M 2024-12
Vertex Pharmaceuticals USD 1.3B 15.8M 2025-09


Puma Biotechnology Bénéfice Avant Impôts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.